Intrinsic Value of S&P & Nasdaq Contact Us

Accolade, Inc. ACCD NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
40/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.03
+0.1%

Accolade, Inc. (ACCD) reported total assets of $647.45M and total liabilities of $334.45M for quarter ending 2024-11-30, resulting in total equity of $313M.

The company held $225.48M in cash and short-term investments. Total debt stood at $28.49M, with net debt of $-157.43M. The Debt-to-Equity (D/E) ratio was 0.09 (conservative).

Current ratio is 2.63, indicating strong short-term liquidity.

Criteria supported by this page:

  • HEALTH (75/100, Pass) — Debt-to-Equity of 0.09, current ratio of 2.63 — balance sheet is strong
  • MOAT (53/100) — Total assets $647.45M and equity $313M support the company's competitive scale
  • VALUE (50/100) — Debt-to-Equity 0.09 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 40/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
40/100
SG Score
View full scorecard →
~
VALUE
50/100
Price-to-Earnings & upside
→ Valuation
FUTURE
34/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
75/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
53/100
Proven by this page
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income
Accolade, Inc. Balance Sheet History
Metric Q3 FY2025 Q2 FY2025 Q1 FY2025 Q4 FY2024
Total Assets $647.45M$756.07M$767.37M$788.15M
Total Liabilities $334.45M$333M$332.1M$342.69M
Total Debt $28.49M$238.81M$240.6M$241.65M
Cash & Investments $225.48M$234.35M$230.64M$237.03M
Total Stockholders Equity $313M$423.07M$435.27M$445.47M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message